Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Novel Sustained Release Ocular Implants PolyActiva, a clinical-stage ...
1. Complete a family collaboration form. All questions on the form are optional. Please complete at your comfort level. 2. Schedule a presentation date. (You will be contacted by a family mentor) 3.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results